Metabolomics in various Diseases
Metabolomics is a novel approach that potentials to enable the detection of states of disease, to categories the patients based on biochemical profiles and to monitor disease progression. Metabolomic analysis may also be able to orient the choice of therapy, identify responders and predict toxicity, paving the way to a customized therapy.
- Metabolomics in Neuropsychiatric Disorders: Metabolomics approach has revealed new opportunities in diagnostics of devastating disorders like neuropsychiatric disorders. Metabolomics-based technologies have the prospective to map early biochemical fluctuations in disease and hence provide a prospect to develop predictive biomarkers that can be used as indicators of pathological deviations prior to development of clinical symptoms of neuropsychiatric disorders.
- Metabolomics in Metabolic Disorders: Metabolomics uses in the identification of metabolites not previously associated with metabolic traits highlight the importance and agitations of particular metabolites and advances novel strategies to prevent type 2 diabetes and illustrate biomarkers that can help with early detection, disease progression and therapeutic response. Consequently, the use of metabolomics in this area will continue to grow in basic research science and clinical medical applications.
- Metabolomics in Cardiovascular Diseases: Cardiovascular diseases are the leading causes of death worldwide. There is a need for the development of particular diagnostic techniques, more effective therapeutic procedures as well as drugs, which can decrease the mortality rate in the course of CVDs. Metabolomic technologies may serve as diagnostic and/or prognostic tools that have the potential to significantly alter the management of CVD. Metabolomics can assist in the interpretation of perturbed metabolic processes, and improves our ability to understand the pathology of ischemic heart disease, atherosclerosis, and heart failure.
- Metabolomic studies in Rheumatoid Arthritis: Metabolites from the nucleic acid and oxidative stress pathways are potential biomarkers for rheumatoid arthritis pathology. Metabolite profiles in rheumatoid arthritis plasma are associated to disease activity and treatment response. Metabolomic studies confirm the hypoxic nature of the inflamed synovial joint in rheumatoid arthritis.
- Metabolomic studies in Systemic Lupus Erythematous: Low histidine levels have been identified in the serum of systemic lupus erythematosus (SLE) and RA could explain the increased incidence of cardiovascular disease observed for both rheumatic diseases. Taurine and citrate levels in the SLE urine metabolome have potential utility as biomarkers for SLE nephritis subtype discrimination.
- studies in Ankylosing Spondylitis: Metabolite levels in serum reflect an alteration in the vitamin D3 metabolism in ankylosing spondylitis. Metabolomic studies of patients and controls identified reduced levels of tryptophan in ankylosing spondylitis, probably due to IFN-γ expression in the disease.
- Metabolomic studies in Psoriatic Arthritis: To date, no studies have directly compared psoriatic arthritis and psoriasis metabolomics profiles. The urine metabolome in psoriatic arthritis is correlated with the changes in disease activity induced by anti-TNF treatment.
- Metabolomic studies in Osteoarthritis: The prediction model built from the urine metabolite concentrations correlates significantly with the Kellgren–Lawrence radiographic scores of osteoarthritis severity. The valine/histidine and the xleucine(isoleucine and leucine)/histidine ratios are potential biomarkers of the development of knee osteoarthritis.
- Metabolomic studies in Gouty Arthritis: Uric acid is not a sufficiently informative biomarker of gouty arthritis and additional markers must be identified. Gouty arthritis also expresses the common core of serum metabolites found in other prevalent arthritis. This common set of metabolites could be useful for the development of improved diagnostic systems.
- Metabolomics in Nephrology: The application of metabolomics in nephrology research has expanded from the initial analyses of uraemia to include both cross-sectional and longitudinal studies of earlier stages of kidney disease. Chronic kidney disease, Diabetic nephropathy, Acute kidney injury, Kidney transplantation and End-stage renal disease
- Metabolomics in Neuropsychiatric Disorders
- Metabolomics in Metabolic Disorders
- Metabolomics in Cardiovascular Diseases
- Metabolomic studies in Rheumatoid Arthritis
- Metabolomic studies in Systemic Lupus Erythematous
- Metabolomic studies in Ankylosing Spondylitis
- Metabolomic studies in Psoriatic Arthritis
- Metabolomic studies in Osteoarthritis
- Metabolomic studies in Gouty Arthritis
- Metabolomics in Nephrology
Related Conference of Metabolomics in various Diseases
June 28-30 2020
globalbiotechnology-cs-2020
June 28-30 2020
oilgas-cs-2020
June 28-30 2020
BEHAVIOURAL SCIENCE-2020
June 28-30 2020
Bioinfo 2020
May 18-19, 2020
13th International Conference on Proteomics, Genomics and Bioinformatics
Osaka, Japan
August 19-20, 2020
2nd International Conference on Biomedical and Clinical Research
Hong Kong, Hong Kong
September 28-29, 2020
6th International Conference on Enzymology and Protein Chemistry
Barcelona, Spain
September 28-29, 2020
2nd International Conference on Metabolomics, Genomics and Proteomics
Singapore City, Singapore
October 12-13, 2020
16th International Conference on Structural and Molecular Biology
Manila, Philippines
Metabolomics in various Diseases Conference Speakers
Recommended Sessions
- Analytical Techniques in Metabolomics
- Computational Methodologies
- Mass Spectroscopy (Ms) based Metabolomics
- Metabolic Modelling and Synthetic Biology
- Metabolomic in the field of Paediatric Medicine
- Metabolomics
- Metabolomics Applications
- Metabolomics Approaches
- Metabolomics in detection of Chemotoxicity
- Metabolomics in Discovering Biomarkers
- Metabolomics in Drug Discovery
- Metabolomics in Nutrition Research
- Metabolomics in Pharmaceutics
- Metabolomics in Precision Medicine
- Metabolomics in Systems Biology
- Metabolomics in the field Of Oncology / Cancer Metabolomic
- Metabolomics in various Diseases
- Nmr-based Metabolomics
- Pharmaco-metabolomics
- Plant and Environmental Metabolomics
- Systems Biology
Related Journals
Are you interested in
- 3-D Structure Determination - Euro Structural Biology 2020 (Netherlands)
- 3-D Structure Determination - Structural Biology 2020 (Spain)
- 3D Structure Determination - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Advancements in structural Biology - Structural Biology 2020 (Spain)
- Advancements in structural Biology - Euro Structural Biology 2020 (Netherlands)
- Advances in BABE - Euro BABE 2020 (France)
- Advances in cellular and molecular biology - Enzyme 2020 (Italy)
- Analytical Techniques in Metabolomics - eurometabolomics-2020 (France)
- Anti-Aging and Functional Medicine - TISSUE REGEN 2020 (Malaysia)
- Artificial Organs - TISSUE REGEN 2020 (Malaysia)
- Assessment of Bioequivalence - Euro BABE 2020 (France)
- BA/BE studies of Biologics and Biosimilars - Euro BABE 2020 (France)
- Bio banking - TISSUE REGEN 2020 (Malaysia)
- Bioavailability - Euro BABE 2020 (France)
- Biochemistry - Glycobiology 2020 (Austria)
- Biochemistry and Biophysics - Structural Biology 2020 (Spain)
- Biochemistry and Biophysics - Euro Structural Biology 2020 (Netherlands)
- Bioequivalence - Euro BABE 2020 (France)
- Bioequivalence Protocols: In vivo/ In vitro studies - Euro BABE 2020 (France)
- Bioinformatics and Computational Biology - Proteomics 2020 (Japan)
- Biological Imaging, Bio mechanics & Bio molecular Engineering - Enzyme 2020 (Italy)
- Biomarkers - Euro Structural Biology 2020 (Netherlands)
- Biomaterials & Bioengineering - TISSUE REGEN 2020 (Malaysia)
- Biomedical Sciences in Bioinformatics - Proteomics 2020 (Japan)
- Biomedicine - TISSUE REGEN 2020 (Malaysia)
- Cancer genomics - METABOLOMICS CONGRESS 2020 (Singapore)
- Cancer Metabolomics Approaches - METABOLOMICS CONGRESS 2020 (Singapore)
- Cancer Therapy - TISSUE REGEN 2020 (Malaysia)
- Cellular and Gene Therapies - TISSUE REGEN 2020 (Malaysia)
- Challenges in Drug Design - Euro BABE 2020 (France)
- Challenges in Drug Development - Euro BABE 2020 (France)
- Clinical Enzymology & Enzyme engineering - Enzyme 2020 (Italy)
- Clinical genomics - METABOLOMICS CONGRESS 2020 (Singapore)
- Clinical Metabolomics - METABOLOMICS CONGRESS 2020 (Singapore)
- Clinical Pharmacology and Therapeutics - Euro BABE 2020 (France)
- Clinical Trails - Euro BABE 2020 (France)
- Complexity Arenas of Structural Biology - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Computational Approach in Structural Biology - Structural Biology 2020 (Spain)
- Computational Approaches in Structural Biology - Euro Structural Biology 2020 (Netherlands)
- Computational Approaches in Structural Biology - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Computational Enzymology - Enzyme 2020 (Italy)
- Computational Methodologies - eurometabolomics-2020 (France)
- Contract Research Organization - Euro BABE 2020 (France)
- Current approach in biochemical techniques & Regenerative Drug - Enzyme 2020 (Italy)
- Drug Designing - Euro Structural Biology 2020 (Netherlands)
- Drug Designing and Biomarkers - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Drug Designing and Biomarkers - Structural Biology 2020 (Spain)
- Enzyme discovery - Enzyme 2020 (Italy)
- Enzyme engineering and recombinant enzyme technology - Enzyme 2020 (Italy)
- Enzyme Nanotechnology - Proteomics 2020 (Japan)
- Enzymes in Food Technology - Enzyme 2020 (Italy)
- Epigenomics and Epigenetics - Proteomics 2020 (Japan)
- Evolution of Glycan Diversity - Glycobiology 2020 (Austria)
- Factors Affecting Bioavailability - Euro BABE 2020 (France)
- Food and Nutritional Metabolomics - METABOLOMICS CONGRESS 2020 (Singapore)
- Frontiers in Structural Biology - Structural Biology 2020 (Spain)
- Frontiers in Structural Biology - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Frontiers in Structural Biology - Euro Structural Biology 2020 (Netherlands)
- Gene regulation and cell signaling - Euro Structural Biology 2020 (Netherlands)
- Gene regulation and Cell Signalling - Structural Biology 2020 (Spain)
- Gene Therapy and Genetic Counselling - Proteomics 2020 (Japan)
- Genome Informatics - Euro Structural Biology 2020 (Netherlands)
- Genomics - METABOLOMICS CONGRESS 2020 (Singapore)
- Genomics - Proteomics 2020 (Japan)
- Genomics and Metabolomics - Glycobiology 2020 (Austria)
- Glycan’s - Glycobiology 2020 (Austria)
- Glycans in Diseases and Therapeutics - Glycobiology 2020 (Austria)
- Glycans in Drug Design - Glycobiology 2020 (Austria)
- Glycobiology - Glycobiology 2020 (Austria)
- Glycochemistry - Glycobiology 2020 (Austria)
- Glycoimmunology - Glycobiology 2020 (Austria)
- Glycoinformatics - Glycobiology 2020 (Austria)
- Glycolipids and Glycopeptides - Glycobiology 2020 (Austria)
- Glyconeurobiology - Glycobiology 2020 (Austria)
- Glycopathology - Glycobiology 2020 (Austria)
- Glycoscience - Glycobiology 2020 (Austria)
- Hybrid Approaches for Structure Prediction - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Hybrid approaches in Structure prediction - Structural Biology 2020 (Spain)
- Immunology & Immunogenetics - Proteomics 2020 (Japan)
- Integrating Transcriptomics & Proteomics - Proteomics 2020 (Japan)
- Introduction to the CRISPR/Cas9 system and Genome Editing - Enzyme 2020 (Italy)
- Machine Learning in Bioinformatics - Proteomics 2020 (Japan)
- Macro molecular Biochemistry & Tissue Engineering - Enzyme 2020 (Italy)
- Managing BA/BE Studies - Euro BABE 2020 (France)
- Mass Spectrometry Proteomics - Proteomics 2020 (Japan)
- Mass Spectroscopy (Ms) based Metabolomics - eurometabolomics-2020 (France)
- Metabolic Modelling and Synthetic Biology - eurometabolomics-2020 (France)
- Metabolomic in the field of Paediatric Medicine - eurometabolomics-2020 (France)
- Metabolomics - eurometabolomics-2020 (France)
- Metabolomics Applications - eurometabolomics-2020 (France)
- Metabolomics Approaches - eurometabolomics-2020 (France)
- Metabolomics in detection of Chemotoxicity - eurometabolomics-2020 (France)
- Metabolomics in Discovering Biomarkers - eurometabolomics-2020 (France)
- Metabolomics in Drug Discovery - eurometabolomics-2020 (France)
- Metabolomics in Nutrition Research - eurometabolomics-2020 (France)
- Metabolomics in Pharmaceutics - eurometabolomics-2020 (France)
- Metabolomics in Precision Medicine - eurometabolomics-2020 (France)
- Metabolomics in Systems Biology - eurometabolomics-2020 (France)
- Metabolomics in the field Of Oncology / Cancer Metabolomic - eurometabolomics-2020 (France)
- Metabolomics in various Diseases - METABOLOMICS CONGRESS 2020 (Singapore)
- Metabolomics in various Diseases - eurometabolomics-2020 (France)
- Molecular Biology - Structural Biology 2020 (Spain)
- Molecular Biology - Euro Structural Biology 2020 (Netherlands)
- Molecular Biology Applications - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Molecular Biology Techniques - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Molecular biology techniques - Structural Biology 2020 (Spain)
- Molecular Enzymology & Enzyme mechanisms - Enzyme 2020 (Italy)
- Molecular Modeling and Dynamics - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Molecular Modelling and Dynamics - Structural Biology 2020 (Spain)
- Molecular Modelling and Dynamics - Euro Structural Biology 2020 (Netherlands)
- Nanotechnology in Tissue Engineering - TISSUE REGEN 2020 (Malaysia)
- Next generation sequencing and other techniques - Proteomics 2020 (Japan)
- NMR & Mass Spectrophotometry - Euro Structural Biology 2020 (Netherlands)
- Nmr-based Metabolomics - eurometabolomics-2020 (France)
- Nutrient Bioavailability - Euro BABE 2020 (France)
- Pharma Clinical Trails - Euro BABE 2020 (France)
- Pharmaceutical Industry: Entrepreneurs Investment Meet - Euro BABE 2020 (France)
- Pharmaco-metabolomics - eurometabolomics-2020 (France)
- Pharmacogenomics - Proteomics 2020 (Japan)
- Plant and Environmental Metabolomics - METABOLOMICS CONGRESS 2020 (Singapore)
- Plant and Environmental Metabolomics - eurometabolomics-2020 (France)
- Protein Biochemistry - Proteomics 2020 (Japan)
- Protein Expression and Analysis - METABOLOMICS CONGRESS 2020 (Singapore)
- Protein Sequencing & Molecular Interactions - Proteomics 2020 (Japan)
- Protein Structure - Proteomics 2020 (Japan)
- Proteoglycan and Sialic acid - Glycobiology 2020 (Austria)
- Proteomics and Genomics - Euro Structural Biology 2020 (Netherlands)
- Proteomics and Genomics - Structural Biology 2020 (Spain)
- Proteomics and Genomics - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Proteomics for Bioinformatics - Proteomics 2020 (Japan)
- Proteomics in Plant & Animal - Proteomics 2020 (Japan)
- Recent Advances in Glycobiology - Glycobiology 2020 (Austria)
- Regenerative Medicine - TISSUE REGEN 2020 (Malaysia)
- Regenerative Rehabilitation - TISSUE REGEN 2020 (Malaysia)
- Regulatory Requirements for Bioequivalence - Euro BABE 2020 (France)
- Sequencing - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Sequencing Analysis - Structural Biology 2020 (Spain)
- Sequencing analysis - Euro Structural Biology 2020 (Netherlands)
- Signaling Biology Biomarkers - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Significance of BA/BE Studies - Euro BABE 2020 (France)
- Soft Tissue Replacement - TISSUE REGEN 2020 (Malaysia)
- Stem Cell Therapies in Gynaecology - TISSUE REGEN 2020 (Malaysia)
- Stem Cell Therapy - TISSUE REGEN 2020 (Malaysia)
- Structural Biochemistry and Single Molecules - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Structural Biochemistry, Synthetic Biology & Tissue Engineering - Enzyme 2020 (Italy)
- Structural Bioinformatics - Euro Structural Biology 2020 (Netherlands)
- Structural Bioinformatics - Structural Biology 2020 (Spain)
- Structural Biology - Euro Structural Biology 2020 (Netherlands)
- Structural Biology - Structural Biology 2020 (Spain)
- Structural Biology Databases - Structural Biology 2020 (Spain)
- Structural Biology in Cancer Research - Structural Biology 2020 (Spain)
- Structural Biology in Cancer Therapeutics - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Structural Enzymology - Structural Biology 2020 (Spain)
- Structural Enzymology - Euro Structural Biology 2020 (Netherlands)
- Structural Genomics - Proteomics 2020 (Japan)
- Structural Virology - Euro Structural Biology 2020 (Netherlands)
- Structural Virology - STRUCTURAL BIOLOGY CONGRESS 2020 (Philippines)
- Study Designs - Euro BABE 2020 (France)
- Synthesis and Biological Role of Glycans - Glycobiology 2020 (Austria)
- Systems Biology - eurometabolomics-2020 (France)
- Systems Biology & Computational Biology - Proteomics 2020 (Japan)
- Tissue Science - TISSUE REGEN 2020 (Malaysia)
- Wound care - TISSUE REGEN 2020 (Malaysia)